Literature DB >> 16154863

Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support.

Hannes Wandt, Kerstin Schaefer-Eckart, Martin Wilhelm.   

Abstract

We successfully performed two allogeneic hematopoietic stem cell transplantations from matched unrelated donors without the use of blood-product support after treosulfan-based conditioning in two women with acute myeloid leukemia who were Jehovah's witnesses and refused transfusions of blood products.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16154863

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  3 in total

1.  Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Authors:  Roswitha Lüftinger; Natalia Zubarovskaya; Christina Peters; Arjan Lankester; Selim Corbacioglu; Jacques-Emmanuel Galimard; Annamaria Cseh; Elisabeth Salzer; Franco Locatelli; Mattia Algeri; Akif Yesilipek; Josu de la Fuente; Antonella Isgrò; Amal Alseraihy; Emanuele Angelucci; Frans J Smiers; Giorgia La La Nasa; Marco Zecca; Tunc Fisgin; Emel Unal; Katharina Kleinschmidt
Journal:  Ann Hematol       Date:  2022-01-09       Impact factor: 3.673

2.  Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia.

Authors:  Hege Garelius; Sofia Grund; Dick Stockelberg
Journal:  Clin Case Rep       Date:  2015-02-13

3.  A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.

Authors:  Yumi Yamamoto; Akihito Kawashima; Eri Kashiwagi; Kiyoyuki Ogata
Journal:  Case Rep Hematol       Date:  2014-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.